Publisher
Springer Science and Business Media LLC
Subject
Anesthesiology and Pain Medicine
Reference36 articles.
1. Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin North Am. 2014;34(2):283–95. https://doi.org/10.1016/j.iac.2014.01.003.
2. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nunez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25(7):603–25. https://doi.org/10.1016/s0145-2126(01)00038-8.
3. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405. https://doi.org/10.1182/blood-2016-03-643544.
4. Castells MC, Akin C. Mastocytosis (cutaneous and systemic) in children: epidemiology, clinical manifestations, evaluation, and diagnosis. 2022. https://www.uptodate.com/contents/mastocytosis-cutaneous-and-systemic-in-children-epidemiology-clinical-manifestations-evaluation-and-diagnosis. Accessed 31 Jan 2023.
5. Romantowski J, Gorska A, Niedoszytko M, Gulen T, Gruchala-Niedoszytko M, Nedoszytko B, Lange M, Brockow K, Arock M, Akin C, Valent P. A challenge for allergologist: application of allergy diagnostic methods in mast cell disorders. Int J Mol Sci. 2021;22(3):1454. https://doi.org/10.3390/ijms22031454.